Clinical trial
A Trial Comparing Treatment With Tiotropium Inhalation Capsules to Combivent…
NCT00359788 · Boehringer Ingelheim, Industry · Completed
Key facts
| NCT number | NCT00359788 |
|---|---|
| Title | A Trial Comparing Treatment With Tiotropium Inhalation Capsules to Combivent Inhalation Aerosol in COPD Patients. |
| Official title | A Randomized, Double-blind, Parallel Group Trial Comparing 12 Weeks Treatment With Tiotropium 18 mcg Daily to Combivent MDI 2 Actuations Qid in COPD Patients Previously Prescribed Combivent MDI |
| Lead sponsor | Boehringer Ingelheim, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Pulmonary Disease, Chronic Obstructive |
| Intervention type | Drug |
| Interventions | tiotropium, Combivent (Ipratropium/Albuterol) |
| Enrollment | 349 |
| Start date | Jul 1, 2006 |
| Primary completion | Apr 1, 2008 |
| First posted | Aug 2, 2006 |
| Last update posted | May 16, 2014 |
| Countries | United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: